LeonaBio (LONA) Long-Term Investments (2020 - 2023)

LeonaBio (LONA) has 4 years of Long-Term Investments data on file, last reported at $10.2 million in Q2 2023.

• Long-Term Investments for Q2 2023 came in at $10.2 million, down 65.77% year-over-year; the trailing twelve-month figure through Jun 2023 was $10.2 million (down 65.77% YoY), and the FY2022 annual result was $44.8 million, down 32.01% from the prior year.
• Long-Term Investments eased to $10.2 million in Q2 2023 per LONA's latest filing, from $33.9 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $103.6 million in Q3 2021 and troughed at $10.2 million in Q2 2023.
• A 4-year average of $50.1 million and a median of $41.9 million in 2022 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2021 and 2023: Long-Term Investments jumped 207.97% in 2021, then sank 65.77% in 2023.
• A 4-year view of Long-Term Investments shows it stood at $83.5 million in 2020, then dropped by 21.04% to $65.9 million in 2021, then slumped by 32.01% to $44.8 million in 2022, then plunged by 77.21% to $10.2 million in 2023.
• Business Quant data shows LONA's Long-Term Investments at $10.2 million in Q2 2023, $33.9 million in Q1 2023, and $44.8 million in Q4 2022.